Unique therapy helps patient beat prostate cancer
Focal therapy, a treatment unique to the region and only offered at UC, helped Richard Weiss, 72, overcome prostate cancer with minimal side effects.
A diagnosis with prostate cancer was something Dick Weiss, 72, was not anticipating in May 2017, after his prostate-specific antigen (PSA) test came back higher than normal. After finding his way to a support group in Blue Ash for men with prostate cancer, he encountered experts from the University of Cincinnati Cancer Institute who were offering unique procedures, not offered elsewhere in the Tristate, to treat this type of cancer.
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.